U.S. National Authority for the WHO Global Code of Practice on the International Recruitment of Health Personnel; Notice of Public Meeting, 23281-23282 [2018-10634]
Download as PDF
<![CDATA[
23281
Federal Register / Vol. 83, No. 97 / Friday, May 18, 2018 / Notices
Dated: May 15, 2018.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
[FR Doc. 2018–10672 Filed 5–17–18; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review;
Comment Request
Title: Preventing and Addressing
Intimate Violence When Engaging Dads.
OMB No.: New Collection.
Description: The Administration for
Children and Families (ACF), Office of
Planning, Research, and Evaluation
(OPRE) proposes to collect information
as part of the Preventing and Addressing
Intimate Violence when Engaging Dads
(PAIVED) study. Since 2006, the
Healthy Marriage and Responsible
Fatherhood (HMRF) initiative has
funded programs that play a key role in
helping the Office of Family Assistance
(OFA) achieve its goals to foster
economically secure households and
communities for the well-being and
long-term success of children and
families. The purpose of the PAIVED
study is to better understand the
prevalence of intimate partner violence
(IPV) experienced by the population of
fathers served by Responsible
Fatherhood (RF) programs, and the
services that federally- and nonfederally funded RF programs are
providing to address and contribute to
the prevention of IPV among its
participants.
The proposed data collection will
include whether IPV content is included
in RF programs, the types of activities
they are using to address IPV, and
related successes and challenges. Other
collected data will include barriers to
addressing IPV in RF programs, the
relevance of addressing IPV with
fathers, fathers’ reactions to this
programming, and what types of
partnerships RF programs have with
other agencies to address IPV. This
information will be collected through
interviews conducted over the phone
and in-person with RF program staff and
community partners. This information
will be critical to inform future efforts
to address and contribute to the
prevention of IPV through RF
programming.
Respondents: Responsible Fatherhood
program staff (e.g., program directors
and facilitators) and community
partners.
ANNUAL BURDEN ESTIMATES
Total number
of respondents
Instrument
Number of
responses per
respondent
50
25
15
1
1
1
daltland on DSKBBV9HB2PROD with NOTICES
RF program/community partner screening and participant recruitment ..........
RF program staff semi-structured interview ....................................................
Community partner semi-structured interview .................................................
Estimated Total Annual Burden
Hours: 111.
Additional Information: Copies of the
proposed collection may be obtained by
writing to the Administration for
Children and Families, Office of
Planning, Research and Evaluation, 330
C Street SW, Washington, DC 20201,
Attn: OPRE Reports Clearance Officer.
All requests should be identified by the
title of the information collection. Email
address: OPREinfocollection@
acf.hhs.gov.
OMB Comment: OMB is required to
make a decision concerning the
collection of information between 30
and 60 days after publication of this
document in the Federal Register.
Therefore, a comment is best assured of
having its full effect if OMB receives it
within 30 days of publication. Written
comments and recommendations for the
proposed information collection should
be sent directly to the following: Office
of Management and Budget, Paperwork
Reduction Project, Email: OIRA_
SUBMISSION@OMB.EOP.GOV, Attn:
Desk Officer for the Administration for
Children and Families.
Mary Jones,
ACF/OPRE Certifying Officer.
[FR Doc. 2018–10656 Filed 5–17–18; 8:45 am]
BILLING CODE 4184–73–P
VerDate Sep<11>2014
16:38 May 17, 2018
Jkt 244001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
U.S. National Authority for the WHO
Global Code of Practice on the
International Recruitment of Health
Personnel; Notice of Public Meeting
Time and date: Monday, July 2, 2018,
2:00 p.m.–4:00 p.m. EST.
Place: Hubert H. Humphrey Building,
Room 325A, 200 Independence Ave.
SW, Washington, District of Columbia
20201.
Status: Open, but requiring RSVP to
us.who.irhp@hhs.gov by Monday, June
25, 2018.
Purpose: The purpose of the World
Health Organization (WHO) Global Code
of Practice on International Recruitment
of Health Personnel (Global Code) is ‘‘to
establish and promote voluntary
principles and practices for the ethical
international recruitment of health
personnel and to facilitate the
strengthening of health systems.’’ The
United States Government has
designated the Office of Global Affairs
(OGA) and the Health Resources and
Services Administration (HRSA) as coNational Authorities to be the point of
contact for implementation activities.
The Global Code encourages WHO
Member States to cooperate with all
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
Average
burden hours
per response
1
1.5
1.5
Annual
burden hours
50
38
23
relevant stakeholders in their
implementation efforts. This meeting is
intended to provide an update to all
interested stakeholders on U.S. Global
Code implementation efforts to date and
to provide a forum for questions on
activities related to implementation of
the Global Code.
The meeting will be open to the
public as indicated above, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify within their RSVP at least 10
business days prior to the meeting.
Foreign nationals planning to attend the
session in person will require additional
paperwork for security clearance and
that this clearance process requires a
minimum of 10 business days.
RSVP: Due to security restrictions for
entry into the HHS Humphrey Federal
Building, we will need to receive RSVPs
for this event. Please send your full
name and organization to us.who.irhp@
hhs.gov. If you are not a U.S. citizen,
you must RSVP no later than Monday,
June 18, 2018. Please note this in the
subject line of your RSVP, and our office
will contact you to gain additional
biographical information for your
E:\FR\FM\18MYN1.SGM
18MYN1
23282
Federal Register / Vol. 83, No. 97 / Friday, May 18, 2018 / Notices
clearance. For U.S. citizens, please
RSVP no later than Monday, June 25,
2018. Written comments are welcome
and encouraged, even if you are
planning to attend in person. Please
send them to the email address:
us.who.irhp@hhs.gov.
Dated: May 9, 2018.
G. Garrett Grigsby,
Director for Global Affairs.
[FR Doc. 2018–10634 Filed 5–17–18; 8:45 am]
BILLING CODE 4150–38–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Findings of Research Misconduct
Office of the Secretary, HHS.
ACTION: Notice.
AGENCY:
Findings of research
misconduct have been made on the part
of Maria Cristina Miron Elqutub,
Research Interviewer, University of
Texas MD Anderson Cancer Center
(MDACC). Dr. Elqutub engaged in
research misconduct in research
supported by National Institute of
Dental and Craniofacial Research
(NIDCR), National Institutes of Health
(NIH), grant U01 DE019765–01. The
administrative actions, including three
(3) years of supervision, were
implemented beginning on April 26,
2018, and are detailed below.
FOR FURTHER INFORMATION CONTACT:
Wanda K. Jones, Dr.P.H., Interim
Director, Office of Research Integrity,
1101 Wootton Parkway, Suite 750,
Rockville, MD 20852, (240) 453–8200.
SUPPLEMENTARY INFORMATION: Notice is
hereby given that the Office of Research
Integrity (ORI) has taken final action in
the following case:
Maria Cristina Miron Elqutub,
University of Texas MD Anderson
Cancer Center: Based on Respondent’s
admission, the report of an inquiry
conducted by MDACC, and analysis
conducted by ORI in its oversight
review, ORI found that Ms. Maria
Cristina Miron Elqutub, Research
Interviewer, MDACC, engaged in
research misconduct in research
supported by NIDCR, NIH, grant U01
DE019765–01.
ORI found that Respondent engaged
in research misconduct by intentionally
and knowingly falsifying and/or
fabricating data that were included in
the following two (2) published papers
and two (2) grant progress reports
submitted to NIDCR, NIH:
• PLoS One 10(6):e0128753, 2015 Jun
2 (hereafter referred to as ‘‘PLoS One
2015’’).
daltland on DSKBBV9HB2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
16:38 May 17, 2018
Jkt 244001
• Cancer 121(14):2367–74, 2015 Jul
15 (hereafter referred to as ‘‘Cancer
2015’’) Retracted in: Cancer 124(4):869,
2018 Feb 15.
• 5 U01 DE019765–04.
• 5 U01 DE019765–05.
Specifically, ORI found that
Respondent engaged in research
misconduct by recording dates and
providing her own blood samples to
cause these samples to be falsely labeled
as samples from ninety-eight (98) study
subjects in a cancer genetics study
involving human blood samples. This
resulted in the reporting of false data in
Tables 1, 2, 3, and 4 in PLoS One 2015,
in Figure 1 and Tables 1, 2, 3, and 4 in
Cancer 2015, and in the Results sections
of Project 2 progress reports for NIDCR,
NIH, grants 5 U01 DE019765–04 and 5
U01 DE019765–05.
Ms. Elqutub entered into a Voluntary
Settlement Agreement and voluntarily
agreed, beginning on April 26, 2018:
(1) To have her research supervised
for a period of three (3) years;
Respondent agreed to ensure that prior
to the submission of an application for
U.S. Public Health Service (PHS)
support for a research project on which
Respondent’s participation is proposed
and prior to Respondent’s participation
in any capacity on PHS-supported
research, the institution employing her
must submit a plan for supervision of
Respondent’s duties to ORI for approval;
the supervision plan must be designed
to ensure the scientific integrity of
Respondent’s research contribution;
Respondent agreed that she will not
participate in any PHS-supported
research until a supervision plan is
submitted to and approved by ORI;
Respondent agreed to maintain
responsibility for compliance with the
agreed upon supervision plan;
(2) that for a period of three (3) years,
any institution employing her must
submit, in conjunction with each
application for PHS funds, or report,
manuscript, or abstract involving PHSsupported research in which
Respondent is involved, a certification
to ORI that the data provided by
Respondent are based on actual
experiments or are otherwise
legitimately derived and that the data,
procedures, and methodology are
accurately reported in the application,
report, manuscript, or abstract;
(3) if no supervisory plan is provided
to ORI, to provide certification to ORI
on an annual basis for a period of three
(3) years that she has not engaged in,
applied for, or had her name included
on any application, proposal, or other
request for PHS funds without prior
notification to ORI;
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
(4) to exclude herself voluntarily from
serving in any advisory capacity to PHS
including, but not limited to, service on
any PHS advisory committee, board,
and/or peer review committee, or as a
consultant for a period of three (3) years;
and
(5) to the correction or retraction of
PLoS One 10(6):e0128753, 2015 Jun 2.
Wanda K. Jones,
Interim Director, Office of Research Integrity.
[FR Doc. 2018–10592 Filed 5–17–18; 8:45 am]
BILLING CODE 4150–31–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Population Sciences
and Epidemiology Integrated Review Group;
Social Sciences and Population Studies A
Study Section.
Date: June 6, 2018.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Melrose Hotel, 2430 Pennsylvania
Ave. NW, Washington, DC 20037.
Contact Person: Suzanne Ryan, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3139,
MSC 7770, Bethesda, MD 20892, (301) 435–
1712, ryansj@csr.nih.gov.
Name of Committee: Cell Biology
Integrated Review Group; Development—1
Study Section.
Date: June 12, 2018.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Thomas Beres, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5148,
MSC 7840, Bethesda, MD 20892, 301–435–
1175, berestm@mail.nih.gov.
E:\FR\FM\18MYN1.SGM
18MYN1
]]>Agencies
[Federal Register Volume 83, Number 97 (Friday, May 18, 2018)]
[Notices]
[Pages 23281-23282]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-10634]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
U.S. National Authority for the WHO Global Code of Practice on
the International Recruitment of Health Personnel; Notice of Public
Meeting
Time and date: Monday, July 2, 2018, 2:00 p.m.-4:00 p.m. EST.
Place: Hubert H. Humphrey Building, Room 325A, 200 Independence
Ave. SW, Washington, District of Columbia 20201.
Status: Open, but requiring RSVP to [email protected] by Monday,
June 25, 2018.
Purpose: The purpose of the World Health Organization (WHO) Global
Code of Practice on International Recruitment of Health Personnel
(Global Code) is ``to establish and promote voluntary principles and
practices for the ethical international recruitment of health personnel
and to facilitate the strengthening of health systems.'' The United
States Government has designated the Office of Global Affairs (OGA) and
the Health Resources and Services Administration (HRSA) as co-National
Authorities to be the point of contact for implementation activities.
The Global Code encourages WHO Member States to cooperate with all
relevant stakeholders in their implementation efforts. This meeting is
intended to provide an update to all interested stakeholders on U.S.
Global Code implementation efforts to date and to provide a forum for
questions on activities related to implementation of the Global Code.
The meeting will be open to the public as indicated above, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify within their RSVP at
least 10 business days prior to the meeting. Foreign nationals planning
to attend the session in person will require additional paperwork for
security clearance and that this clearance process requires a minimum
of 10 business days.
RSVP: Due to security restrictions for entry into the HHS Humphrey
Federal Building, we will need to receive RSVPs for this event. Please
send your full name and organization to [email protected]. If you are
not a U.S. citizen, you must RSVP no later than Monday, June 18, 2018.
Please note this in the subject line of your RSVP, and our office will
contact you to gain additional biographical information for your
[[Page 23282]]
clearance. For U.S. citizens, please RSVP no later than Monday, June
25, 2018. Written comments are welcome and encouraged, even if you are
planning to attend in person. Please send them to the email address:
[email protected].
Dated: May 9, 2018.
G. Garrett Grigsby,
Director for Global Affairs.
[FR Doc. 2018-10634 Filed 5-17-18; 8:45 am]
BILLING CODE 4150-38-P
